What We’re Investing In: Current investment opportunities on OurCrowd (January 2015)
OurCrowd’s portfolio growth is expanding: this month, featured opportunities include innovative companies in the medical technology and cyber security spaces. Stay tuned – there are more deals to be announced before the end of the month; bookmark this post to view the next deals. TheraCoat: Hydrogel-based drug delivery A major pain point for pharmacologists when developing drugs is finding a substance that can efficiently deliver the needed medication before the body’s natural fluids wash it away. TheraCoat’s Intracavity Drug Retention System (ICDR) was created to solve that very problem. Their patent-protected substance liquefies when in cool temperatures and hardens in hot temperatures. The ICDR is mixed with the necessary drug and taken in liquid form. When the liquid reaches the cavity, body heat causes the substance to harden and stick to the walls of the cavity. This enables the drug to be emitted at a slow, consistent rate, without being washed away by the body’s fluid. So far, TheraCoat has experienced significant early traction, conducting a number of successful test trials and securing regulatory clearance in a number of...
Read More